However, proinsulin has been identified to activate neuroprotective pathways in the hippocampus and trigger a downstream signalling cascade that reduces astrocyte reactivity and neuroinflammatory biomarkers, all of which are involved in the pathogenesis of migraine, headache, and other neurological conditions (Corpas et al. 2017). Here, INS is linked to migraine disorder.